de Korte Beau A C, Smeets Nori J L, Colbers Angela, van den Bemt Bart J F, van Gelder Marleen M H J
Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Gynecology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Br J Clin Pharmacol. 2023 May;89(5):1521-1531. doi: 10.1111/bcp.15609. Epub 2022 Dec 9.
Pregnant women are hypothesized to have low adherence to prescribed medication, because of concerns about harmful effects on the unborn child. However, very little is known about the actual adherence to prescribed medication during pregnancy. We determined to what extent women follow treatment recommendations regarding prescribed medication use in mid-pregnancy.
Dutch women participating in the PRIDE Study completed a 6-week diary on medication use. Additionally, pharmacy records were obtained. For each medication dispensed, we determined 3 measures of adherence: (i) whether use was reported in the diary (actual use); (ii) difference between dispensing date and date of first reported use (initiation time); and (iii) proportion of days with at least the correct number of doses taken (implementation adherence).
During the 6-week study period, 235 of 816 women (29%) were dispensed medication. Actual use was highest for medications used for chronic conditions (88%; 95% confidence interval [95% CI] 81-93), followed by medication for pregnancy-related conditions (79%; 95% CI 71-86) and medication for occasional and short-time use (69%; 95% CI 60-77). We observed a ≥1-day delay in treatment initiation for 42% of medications dispensed for the first time in the study period. Mean implementation adherence was 74.2% (95% CI 69.3-79.2) for medications that were actually used.
Although actual use of medications dispensed was high, many pregnant women did not adhere to treatment recommendations. This nonadherence may impact maternal and child health and lead to overestimation of medication use in studies in perinatal pharmacoepidemiology relying on administrative databases.
据推测,孕妇对处方药的依从性较低,原因是担心对未出生的孩子产生有害影响。然而,关于孕期对处方药的实际依从性知之甚少。我们确定了孕妇在孕中期遵循关于处方药使用的治疗建议的程度。
参与PRIDE研究的荷兰女性完成了一份为期6周的用药日记。此外,还获取了药房记录。对于每种配药,我们确定了3种依从性指标:(i)日记中是否报告了用药情况(实际用药);(ii)配药日期与首次报告用药日期之间的差异(开始用药时间);(iii)至少服用正确剂量天数的比例(用药依从性)。
在为期6周的研究期间,816名女性中有235名(29%)配了药。用于慢性病的药物实际使用率最高(88%;95%置信区间[95%CI]81 - 93),其次是用于与妊娠相关疾病的药物(79%;95%CI 71 - 86)以及偶尔和短期使用的药物(69%;95%CI 60 - 77)。在研究期间首次配药的药物中,我们观察到42%的药物开始治疗有≥1天的延迟。实际使用的药物的平均用药依从性为74.2%(95%CI 69.3 - 79.2)。
尽管配药的实际使用率较高,但许多孕妇并未遵循治疗建议。这种不依从可能会影响母婴健康,并导致在依赖行政数据库的围产期药物流行病学研究中对药物使用的高估。